You have entered the IISP: Interactive Information System on Pathogenomics
If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to firstname.lastname@example.org or email@example.com.
Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .
The following information is available and can be searched for:
- researcher names
- Institution of the respective researcher, city and country of his/her institution
- Contact data of the researcher (address, phone, email)
- Research topics and studied microorganisms of the researcher
- Special techniques applied by the researcher
- Potential cooperation topics suggested by the researcher
If you have any comments/questions or if you would like to add some information, please contact firstname.lastname@example.org
|Name:||Dr. Lecuit, Marc|
|Address:||28, rue du Dr Roux|
|Institution:||Department of Cell Biology and Infection|
|Country:||FRance||Phone:||33 1 40 61 30 29|
|Fax:||33 1 45 68 87 06|
|We are interested in the pathophysiology of human infectious diseases and the molecular basis of host, tissue and cell specificity of microbial pathogens. We are particularly interested in understanding how microbial pathogens target and cross host barriers such as mucosal barriers, the blood-brain barrier, and the placental barrier. We are combining in vitro, ex vivo and in vivo approaches by using cultured cell lines, primary cells, and tissue explants as well as small animal models. We are using molecular techniques in the fields of microbiology and cell biology, as well as "humanized" transgenic animals that take into account the species specificity of human pathogens. Another area of investigation is the putative infectious origin of emerging and orphan human diseases. We are using a range of molecular techniques to discover new microbial pathogens within human tissue samples of patients with such diseases.|
|Special methods / technologies:|
|Suggestions for potential research cooperations:|